RESUMO
Existen pocos estudios científicos que demuestren el valor terapéutico de las plantas usadas en la medicina tradicional centroamericana para tratar el envenenamiento ofídico. En este estudio se evaluó la capacidad de los extractos etanólicos de nueve plantas de uso etnomédico en Centroamérica (Acacia hindsii, Aristolochia maxima, Bursera simaruba, Cissampelos pareira, Eryngium foetidum, Hamelia patens, Pimenta dioica, Piper peltatum y Sansevieria hyacinthoides) para inhibir el efecto coagulante del veneno de Bothrops asper. Tres de ellas (B. simaruba, E. foetidum y P. dioica) también fueron evaluadas en cuanto a su capacidad inhibitoria de los efectos fosfolipasa A2 (PLA2) y proteolítico del veneno. Las plantas fueron colectadas en Guatemala, secadas, extraídas con etanol y los efectos inhibitorios evaluados in vitro después de preincubar concentraciones variables de extracto con concentraciones fijas de veneno. Los resultados demostraron que ninguno de los extractos logró inhibir los efectos coagulante y PLA2, pero los extractos clorofilados de P. dioica y E. foetidum inhibieron efectivamente la actividad proteolítica del veneno. El tamizaje fitoquímico, mediante ensayos macro y semimicrométricos de cromatografía en capa fina, demostró la presencia de metabolitos secundarios reportados con actividad antiproteolítica (flavonoides, antocianinas, catequinas y taninos) en la composición química de los extractos de E. foetidum y P. dioica. Su efecto sobre el veneno se evaluó mediante electroforesis SDS-PAGE, demostrándose que no está mediado por degradación proteolítica de los componentes del veneno. El aislamiento y caracterización específica de sus metabolitos secundarios en futuros estudios, permitirá determinar el mecanismo de acción inhibitoria ejercido por estos extractos.
Medicinal plants have been traditionally used in Central America to treat snakebite envenomations, however, very few scientific studies aimed to demonstrate their efficacy and safety have been performed. In this study, ethanolic extracts of nine plants used in the region by traditional healers in snakebite cases (Acacia hindsii, Aristolochia maxima, Bursera simaruba, Cissampelos pareira, Eryngium foetidum, Hamelia patens, Pimenta dioica, Piper peltatum and Sansevieria hyacinthoides) were evaluated for their ability to inhibit the coagulant effect induced by the venom of the snake Bothrops asper. Three of these extracts (B. simaruba, E. foetidum and P. dioica) were also evaluated for their inhibitory effect on the phospholipase A2 (PLA2) and proteolytic activities of the venom. Plants were collected in Guatemala, dried, extracted with ethanol, and their inhibitory effects were evaluated in vitro after pre-incubation of several amounts of each extract with a challenge concentration of venom. Results showed that none of the extracts inhibited the coagulant and PLA2 effects; however, chlorophyllated extracts of E. foetidum and P. dioica effectively inhibited the proteolytic activity of the venom. Phytochemical analysis of these extracts, conducted by macrometric assays and semimicroanalysis by thin layer chromatography, identified secondary metabolites (flavones, anthocyanins, catequines and tannins) whose anti-proteolytic activities have been widely reported. SDS-PAGE analysis demonstrated that the mechanism of inhibition is not related to proteolytic degradation of the venom proteins by the plant extracts. Further studies are needed to isolate and identify the active venom inhibitory compounds of these plants, aimed to understand their mechanism of action.
Assuntos
Humanos , Masculino , Feminino , Plantas Medicinais/química , Mordeduras de Serpentes , Bothrops/anormalidades , Extratos Vegetais , Medicina Tradicional , Antídotos/administração & dosagem , Antídotos/análiseRESUMO
Objetivo. Identificar las características asociadas con la prevalencia de utilización correcta de la autoexploración manual (AE), el examen clínico (EC) y la mamografía (MA) para la detección de cáncer mamario (CaMa). Material y métodos. Se entrevistó a 1 030 mujeres mexicanas, sanas, de entre 20 y 88 años sobre su historia reproductiva y sociodemográfica. Con base en la forma y frecuencia de realización de estas técnicas de detección, se construyó un índice de utilización correcta. Resultados. La prevalencia de utilización correcta de la AE fue de 11% y del EC de 5.4%. El 7.6% de las mujeres entre 40 y 49 años y 31.6% de las mujeres con 50 años o más se realizaron una MA de acuerdo con la norma vigente al momento del estudio. El aseguramiento por parte del Instituto Mexicano del Seguro Social, del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado o del Seguro Popular fue el principal determinante de la utilización de la MA. Conclusiones. Se evidencia la necesidad de incrementar la correcta utilización de la AE, el EC y la MA.
Objective. Identify the characteristics associated with correct utilization of self examination (SE), clinical exam (CE) and mammography (MA) for breast cancer (BC) early detection. Materials and methods. Interviews were undertaken with 1 030 Mexican women (n=1 030), 20 to 88 years of age, regarding their reproductive and sociodemographic characteristics. An index of correct utilization was constructed based on the form and frequency practice of those techniques. Results. The prevalence of correct utilization of SE was 11% and 5.4% for CE. Further, 7.6% of women 40-49 years of age with 2 or more BC risk factors had MA during the two years prior to the interview, and for 31.6% among women ≥50 years of age the MA was annually. The main determinant of MA utilization was having financial protection from either IMSS, ISSSTE or Seguro Popular. Conclusions. It is necessary to improve the correct utilization of BC detection techniques in Mexico.
Assuntos
Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antídotos/administração & dosagem , Antineoplásicos/administração & dosagem , Neoplasias Colorretais/tratamento farmacológico , Floxuridina/administração & dosagem , Leucovorina/administração & dosagem , Administração Oral , Antineoplásicos/efeitos adversos , Neoplasias Colorretais/mortalidade , Neoplasias Colorretais/patologia , Floxuridina/efeitos adversos , Infusões Intravenosas , Taxa de SobrevidaRESUMO
La fiebre chikungunya (CHIK) es una enfermedad viral transmitida al ser humano por el mismo vector del dengue, el mosquito Aedes. Además de fiebre y fuertes dolores articulares, produce otros síntomas como mialgias, cefalea, náuseas, cansancio y exantema. No tiene tratamiento específico; el manejo terapéutico de los pacientes se enfoca en el alivio de los síntomas. Históricamente se han reportado brotes de grandes proporciones; incluso desde 2010 se llegó a considerar como una potencial epidemia emergente. En 2013 se introdujo a las islas del Caribe y recientemente se ha reportado en el continente americano. En este trabajo se describe el primer caso confirmado de chikungunya en México, en el municipio de Tlajomulco de Zúñiga, Jalisco, en mayo de 2014, importado de la isla Antigua y Barbuda, en el Caribe, por una mujer de 39 años de edad.
Chikungunya fever (CHIK) is a viral disease transmitted to human beings by the same vector as dengue -the Aedes mosquito. Besides fever and severe pain in the joints, it produces other symptoms such as myalgias, headache, nausea, fatigue and exanthema. There is no specific treatment for it; the therapeutic management of patients focuses on symptom relief. Historically, outbreaks of large proportions have been reported; even since 2010 it was considered to be a potential emerging epidemic. In 2013 it was introduced into the islands of the Caribbean, and it has recently been reported in the American continent. This paper describes the first confirmed case of chikungunya in Mexico -in the municipality of Tlajomulco de Zúñiga, Jalisco, in May, 2014-, which was imported from the Caribbean island of Antigua and Barbuda by a 39 year-old woman.
Assuntos
Animais , Bovinos , Masculino , Ratos , Antídotos/farmacologia , Temperatura Alta , Imidazóis/toxicidade , Carne , Mitocôndrias/metabolismo , Mutagênicos/toxicidade , Consumo de Oxigênio/efeitos dos fármacos , Ubiquinona/farmacologia , Antídotos/administração & dosagem , Culinária , Dieta , Complexo II de Transporte de Elétrons , Complexo III da Cadeia de Transporte de Elétrons/metabolismo , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Transporte de Elétrons/efeitos dos fármacos , Alimentos Fortificados , Mitocôndrias Cardíacas/efeitos dos fármacos , Mitocôndrias Cardíacas/metabolismo , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/metabolismo , Mitocôndrias Musculares/efeitos dos fármacos , Mitocôndrias Musculares/metabolismo , Complexos Multienzimáticos/metabolismo , NAD(P)H Desidrogenase (Quinona)/metabolismo , Oxirredutases/metabolismo , Ratos Wistar , Succinato Desidrogenase/metabolismo , Ubiquinona/administração & dosagemRESUMO
In homeopathy some drugs are known to act as complementary, antidotal or inimical to a particular drug. Practitioners can follow this rule when they apply one drug following another. Potentized Nux vomica can reduce acute hypnotic effect of alcohol on toads. Sulphur and Sepia are reported to be complementary to Nux-vom, while Coffea cruda and Zincum met are antidotal and inimical to Nux, respectively [...] Methods: Five batches of toads, each comprising 20 individuals, were treated by partial immersion in a drug diluted with distilled water 1:500 for 20 min. The control consisted of 90% ethanol diluted with distilled water 1:500. The drugs were Nux vom 200 CH, Sulphur 200 CH, Sepia 200 CH, Coffea 200 CH and Zincum 200 CH. Toads of each batch were separately exposed to 260mM ethanol solution and tested every 10 min to see if they had lost their righting reflex (RR)[...] Results: Toads treated with the five drugs took significantly longer time (P<0.01, one-way ANOVA) to lose RR than those treated with the control. The time taken to lose RR was significantly longer (P<0.01, one-way ANOVA) with Sulphur 200 CH, Sepia 200 CH, Coffea 200 CH and Zincum 200 CH than with Nux vom 200 CH alone. The situation was same when Nux treatment was followed by each of the four drugs. Of the five drugs Coffea showed the strongest anti-hypnotic effect. Conclusion: 1. Drugs complementary, antidotal and inimical to Nux vom showed the same anti-alcoholic effect as Nux in terms of increased tolerance to alcohol anesthesia. 2. The anti-alcoholic effect of Nux vom was markedly superseded by the above four drugs. 3. Of all the drugs tested Coffea showed the strongest anti-alcoholic effect. 4. It appears that the above four drugs produced their individual dominant effect cancelling the individual effect of Nux vom.
Assuntos
Animais , Antídotos/administração & dosagem , Etanol/farmacologia , Anuros , Coffea Cruda , Reflexo de Endireitamento , Sepia succus , SulphurRESUMO
Intoxications have become a relevant complaint in the emergency room since the second half of the last century. Toxidromes have been replaced by a more practical combined analysis of vital signs, directed physical examination and selected laboratory tests. Most of the mortality can be prevented by the correct and opportune implementation of general management strategies, including supportive care, prevention of absortion, enhancement of elimination and extracorporeal removal of toxins. Through the following pages we will review many of different diagnostic and therapeutic alternatives...
Assuntos
Humanos , Masculino , Feminino , Intoxicação/classificação , Intoxicação/diagnóstico , Intoxicação/prevenção & controle , Intoxicação/reabilitação , Intoxicação/terapia , Toxicidade/classificação , Toxicidade/prevenção & controle , Antídotos/administração & dosagem , Transtornos Relacionados ao Uso de SubstânciasRESUMO
Background : Aluminum phosphide (AlP) is used as a fumigant. It produces phosphine gas, which is a mitochondrial poison. Unfortunately, there is no known antidote for AlP intoxication, and also, there are few data about its prognostic factors. AIMS: The aim of this study was to determine the impact of the Simplified Acute Physiology Score II (SAPS II ) in the prediction of outcome in patients with acute AlP poisoning requiring admission to the Intensive Care Unit (ICU). Materials and Methods : This was a prospective study in patients with acute AlP poisoning, admitted to the ICU over a period of 12 months. The demographic data were collected and SAPSII was recorded. The patients were divided into survival and non-survival groups due to outcome. Statistical Analysis : The data were expressed as mean ± SD for continuous or discrete variables and as frequency and percentage for categorical variables. The results were compared between the two groups using SPSS software. Results : During the study period, 39 subjects were admitted to the ICU with acute AlP poisoning. All 39 patients required endotracheal intubation and mechanical ventilation in addition to gastric decontamination with sodium bicarbonate, permanganate potassium, and activated charcoal, therapy with MgSO 4 and calcium gluconate and adequate hydration. Among these patients, 26 (66.7%) died. SAPSII was significantly higher in the non-survival group than in the survival group (11.88 ± 4.22 vs. 4.31 ± 2.06, respectively) (P < 0.001). Conclusion : SAPSII calculated within the first 24 hours was recognized as a good prognostic indicator among patients with acute AlP poisoning requiring ICU admission.
Assuntos
Adolescente , Adulto , Compostos de Alumínio/intoxicação , Antídotos/administração & dosagem , Antídotos/uso terapêutico , Carvão Vegetal/administração & dosagem , Carvão Vegetal/uso terapêutico , Feminino , Previsões , Humanos , Masculino , Pessoa de Meia-Idade , Praguicidas/intoxicação , Fosfinas/intoxicação , Intoxicação/diagnóstico , Intoxicação/tratamento farmacológico , Intoxicação/fisiopatologia , Permanganato de Potássio/administração & dosagem , Permanganato de Potássio/uso terapêutico , Estudos Prospectivos , Índice de Gravidade de Doença , Bicarbonato de Sódio/administração & dosagem , Bicarbonato de Sódio/uso terapêutico , Resultado do Tratamento , Adulto JovemRESUMO
La N-acetilcisteina (NAC) es un fármaco con propiedades antidóticas útiles en la intoxicación por compuestos hepatotóxicos, como paraquat, acetaminofen y fósforo inorgánico. No se encuentra fácilmente disponible en Venezuela a pesar que la frecuencia y severidad de este tipo de intoxicación son significativas. Se discuten ciertas características fármacocinéticas y fármacodinámicas de la NAC y de la S-carboximetilcisteina (SCMC), presente en el mercado farmacéutico venezolano. Además se presenta una revisión de las experiencias clínicas y experimentales con la SCMC en intoxicaciones por compuestos hepatototóxicos.
N-acetylcysteine (NAC) is a drug with antidotal properties useful in poisoning by hepatotoxic compounds such as paraquat, acetaminophen and inorganic phosphorus. Although the frequency and severity of this type of poisoning are significant, NAC is not readily available in Venezuela. Certain pharmacokinetic and pharmacodynamic characteristics of NAC and S-carboxymetylcisteine (SCMC), available in venezuelan pharmaceutical market are discussed. In addition, a review of the clinical and experimental experiences with SCMC in poisoning for hepatotoxic compounds is presented.
Assuntos
Humanos , Masculino , Feminino , Acetilcisteína/uso terapêutico , Carbocisteína/uso terapêutico , Doença Hepática Induzida por Substâncias e Drogas/fisiopatologia , Paraquat/toxicidade , Preparações Farmacêuticas/efeitos adversos , Preparações Farmacêuticas , Antídotos/administração & dosagem , Cuidado da Criança , Fígado , Doença MedicamentosaRESUMO
OBJECTIVES: To compare the management of acute paracetamol poisoning with the best evidence available, and to determine the effect of plasma paracetamol level estimation on the management. DESIGN: Descriptive study with an intervention. SETTING: Medical wards of the National Hospital of Sri Lanka, Colombo. PATIENTS: Patients admitted with a history of acute paracetamol poisoning. INTERVENTION: Measurement of plasma paracetamol. METHODS: Data were obtained from the patients, medical staff and medical records. Plasma paracetamol was estimated between 4-24 hours of paracetamol ingestion. The current management practices were compared with the best evidence on acute paracetamol poisoning management. RESULTS: 157 patients were included. The mean ingested dose of paracetamol was 333 mg/kg body weight. Majority of the patients (84%) were transfers. Induced emesis and activated charcoal were given to 91% of patients. N-acetylcysteine was given to 66, methionine to 55, and both to 2. Aclinically important delay in the administration of antidotes was noted; 68% of patients received antidotes after 8 hours of the acute ingestion. Only 31 (26%) had paracetamol levels above the Rumack-Matthew normogram. 74 patients received an antidote despite having a plasma paracetamol level below the toxic level according to the normogram. INTERPRETATION: Management of acute paracetamol poisoning could be improved by following best available evidence and adapting cheaper methods for plasma paracetamol estimation.
Assuntos
Acetaminofen/sangue , Acetilcisteína/administração & dosagem , Doença Aguda , Analgésicos não Narcóticos/sangue , Antídotos/administração & dosagem , Carvão Vegetal/administração & dosagem , Eméticos/administração & dosagem , Medicina Baseada em Evidências , Feminino , Hospitais Públicos , Humanos , Masculino , Metionina/administração & dosagem , Intoxicação/terapia , Bicarbonato de Sódio/administração & dosagem , Sri Lanka , Fatores de Tempo , Resultado do Tratamento , Adulto JovemRESUMO
OBJECTIVE: We aimed to review characteristics of mushrooms and mushroom poisoning and compare clinical picture, laboratory data, treatment modalities and prognostic factors in children with amanita intoxication and non-amanita mushroom poisoning. METHODS: We analyzed 39 pediatric patients through 1994-2004, retrospectively from the patient files and evaluated the patients in two groups as patients with amanita intoxication and patients with non-amanita mushroom poisoning. All of the cases were admitted to the hospital in autumn. Twenty three (59%) of the patients were female and 16 (41%) were male. Mean age of the patients was 8.05 +/- 2.10 years. RESULTS: Amanita phalloides toxin was detected in the serum in 8 patients. Eleven (28%) of the cases were strongly suggestive of amanita poisoning but alpha amanitin level could not be studied. The average time of appearance of symptoms after mushroom consumption, duration of symptoms, hospital stay, serum AST, ALT, PT and creatinine levels were significantly higher in patients with amanita poisoning (p<0.01). Conventional therapy, antidote therapy together with hemoperfusion were carried out in 16 (41%) of the patients. Four of the patients in whose blood amatoxin was detected (50%) and 3 of the patients highly suggestive of amanita poisoning (30%), totally 7 patients died of hepatic coma. The average time of admission to hospital, mean AST, ALT, creatinine and PT values at 3rd day were significantly higher in patients who died of hepatic coma. Prognosis was better in case of early admittance to hospital in patients with amanita poisoning. CONCLUSION: Early diagnosis and treatment in mushroom poisoning can be life saving. Public awareness is very important in prevention of intoxication as well as encouraging early admission to hospitals.
Assuntos
Antídotos/administração & dosagem , Carvão Vegetal/administração & dosagem , Distribuição de Qui-Quadrado , Criança , Diurese , Feminino , Lavagem Gástrica , Hemoperfusão , Humanos , Masculino , Intoxicação Alimentar por Cogumelos/epidemiologia , Prognóstico , Estudos Retrospectivos , Estatísticas não Paramétricas , Turquia/epidemiologiaRESUMO
To investigate the therapeutic effect of high-dosage gamma-aminobutyric acid (GABA) on acute tetramine (TET) poisoning, 50 Kunming mice were divided into 5 groups at random and the antidotal effects of GABA or sodium dimercaptopropane sulfonate (Na-DMPS) on poisoned mice in different groups were observed in order to compare the therapeutic effects of high-dosage GABA with those of Na-DMPS. Slices of brain tissue of the poisoned mice were made to examine pathological changes of cells. The survival analysis was employed. Our results showed that both high-dosage GABA and Na-DMPS could obviously prolong the survival time, delay onset of convulsion and muscular twitch, and ameliorate the symptoms after acute tetramine poisoning in the mice. Better effects could be achieved with earlier use of high dosage GABA or Na-DMPS. There was no significant difference in prolonging the survival time between high-dose GABA and Na-DMPS used immediately after poisioning. It is concluded that high-dosage GABA can effectively antagonize acute toxicity of teramine in mice. And it is suggested that high-dosage GABA may be used as an excellent antidote for acute TET poisoning in clinical practice. The indications and correct dosage for clinical use awaits to be further studied.
Assuntos
Doença Aguda , Antídotos/administração & dosagem , Antídotos/uso terapêutico , Hidrocarbonetos Aromáticos com Pontes/intoxicação , Distribuição Aleatória , Rodenticidas/intoxicação , Unitiol/uso terapêutico , Ácido gama-Aminobutírico/administração & dosagem , Ácido gama-Aminobutírico/uso terapêuticoRESUMO
BACKGROUND: Organophosphorus (OP) compounds are the most common suicidal poison in developing countries and mortality continues to be high. METHODS: A study was done to see butyryl cholinesterase (BuChE) profile after OP poisoning in pralidoxime (P2AM) and placebo treated cases. Highest recommended dose of P2AM was used to study the reactivation of cholinesterase. Clinical outcomes like, correlation of BuChE and severity of poisoning, mortality and complications like Type I and II paralysis, need for ventilation and ICU stay were also studied. RESULTS: Twenty one cases of moderate and severe poisoning with OP compounds were included in the study. Mean BuChE levels came up gradually over 6-7 days, some taking up to two weeks. There was no. difference between the treatment and placebo groups. BuChE levels did not correlate with severity of poisoning nor did it correlate with Type I or II paralysis, need for ventilation, ICU stay or mortality. CONCLUSIONS: Treatment with P2AM does not make any difference in BuChE reactivation or complications of moderate and severe OP poisoning. We have not been using P2AM for OP poisoning in our medical ICU with good patient outcomes.
Assuntos
Antídotos/administração & dosagem , Butirilcolinesterase/sangue , Substâncias para a Guerra Química/intoxicação , Reativadores da Colinesterase/administração & dosagem , Países em Desenvolvimento , Humanos , Exposição Ocupacional/efeitos adversos , Praguicidas/intoxicação , Organofosfatos/intoxicação , Intoxicação/tratamento farmacológico , Compostos de Pralidoxima/administração & dosagem , Tentativa de Suicídio , Resultado do TratamentoRESUMO
Objetivos: O objetivo desta revisão é apresentar, de forma clara e prática, a abordagem terapêutica da criança vítima de intoxicação aaguda. Métodos: Foram revistos artigos da literatura, selecionando-se aqueles que tratam das questões envolvendo o tratamento da intoxicação aguda. Resultados: Intoxicação aguda constitui importante problema da saúde pública, particulalrmente na faixa etária pediátrica. Medicamentos são os principais agentes responsáveis, seguido muito de perto pelas intoxicações por animais peçonhentos. Seguen-se de modo expressivo, as intoxicações por produtos domissanitários, pesticidas e protudos químicos de uso industrial. O atendimento do paciente intoxicado segue uma série de etapas, geralmente, mas não necesseriamente, seqüenciais, que são as seguintes: avaliação clínica inicial e estabilização, fase em que situações de risco de vida são identificadas e atendidas; reconhecimento da toxíndrome e identificação do agente causal, quando se tenta, através da análise de sinais e sintomas, orientar os testes diagnósticos; descontaminaçao, com utilização criteriosa dos métodos disponíveis; administração de antítodos, cujo número comprovadamente eficaz é restrito; aumento da eliminação do tóxico absorvido, que requer reconhecimento da cinética do tóxico; e tratamento sintomático. Conclusões: O reconhecimento da síndrome tóxica bem como o conhecimento das etapas básicas da abordagem de um paciente intoxicados são vitais paro o sucesso do tratamento
Assuntos
Humanos , Criança , Antídotos/administração & dosagem , Descontaminação , Intoxicação/terapia , Acetilcisteína/administração & dosagemAssuntos
Humanos , Criança , Picada de Aranha/diagnóstico , Venenos de Aranha/intoxicação , Antídotos/administração & dosagem , Antídotos/efeitos adversos , Clorfeniramina/uso terapêutico , Técnicas de Laboratório Clínico , Edema/etiologia , Eritema/etiologia , Picada de Aranha/complicações , Picada de Aranha/tratamento farmacológicoRESUMO
El objetivo de este artículo es presentar la información biológica de los organismos marinos venenosos más comunes, el tratamiento médico de algunos de los investigadores más notables en el tema y las medidas más recientes de primeros auxilios para disminuir los efectos de estos venenos, ya que el hecho de que un médico haya empleado una dosis y un tipo de fármaco, no es indicación de que otro pueda emplearlo en una situación similar
Assuntos
Humanos , Criança , Venenos/toxicidade , Venenos de Cnidários/intoxicação , Antídotos/administração & dosagem , Antídotos/uso terapêutico , Primeiros Socorros , Toxinas Marinhas/intoxicaçãoAssuntos
Antídotos/administração & dosagem , Carbamatos/toxicidade , Cáusticos , Hidrocarbonetos , Metanol , Fenitoína , Intoxicação , Toxicologia , Saúde PúblicaAssuntos
Adolescente , Adulto , Antídotos/administração & dosagem , Biomarcadores , Ensaios Clínicos Controlados como Assunto , Feminino , Humanos , Índia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Compostos Organofosforados/intoxicação , Intoxicação/diagnóstico , Compostos de Pralidoxima/administração & dosagem , Butirilcolinesterase/análise , Medição de Risco , Índice de Gravidade de Doença , Resultado do TratamentoAssuntos
Antídotos/administração & dosagem , Ensaios Clínicos como Assunto , Relação Dose-Resposta a Droga , Seguimentos , Guias como Assunto , Humanos , Compostos Organofosforados/intoxicação , Assistência ao Paciente/normas , Intoxicação/diagnóstico , Compostos de Pralidoxima/administração & dosagem , Índice de Gravidade de Doença , Resultado do TratamentoRESUMO
A necessidade de novas terapêuticas com o objetivo de diminuir a recidiva e aumentar a sobrevida dos pacientes com câncer retal tem estimulado a realizaçäo de estudos utilizando radioterapia e quimioterapia pré-operatória, observando-se regressäo completa entre 10 a 30 por cento. Em virtude das vantagens da ultra-sonografia intra-retal no estadiamento do tumor de reto e no diagnóstico de recidiva pélvica no pós-operatório, desenvolveu-se este estudo para avaliar seu valor na confirmaçäo da regressäo completa dos tumores após radioterapia, assim como no estadiamento destes tumores. Os resultados obtidos mostram grande limitaçäo do método em virtude dos efeitos da radioterapia sobre o tumor e sobre a própria parededo reto. Contudo em alguns casos foi útil no seguimento dos pacientes näo operados, devido à regressäo completa após radioterapia, em determinar o reaparecimento ou näo da neoplasia antes dos outros métodos de diagnóstico